Autopsy report · NCT01032148

Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's Lymphoma

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“lack of funding”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 7 years 1 month before it stopped.
8 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Roswell Park Cancer Institute
Sponsor type: University, hospital or other
Conditions: Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma
Interventions: LBH589
Participants: 8
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.